| Product Name | NebuSelect™ Recombinant Human Fas Ligand/TNFSF6, His-tag |
|---|---|
| Catalog Number | NBL-242688 |
| Alias/Synonyms | Fas Ligand/TNFSF6; APTL; CD95-L; Fas ligand; APT1LG1; TNFSF6; FASLG; ALPS1B; CD178; FASL; TNLG1A |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | AAH17502.1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242688-100ug | 100ug | Inquire | Inquire | |
| NBL-242688-1mg | 1mg | Inquire | Inquire | |
| NBL-242688-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Fas Ligand/TNFSF6, His-tag
Catalog#:
NBL-242688
Description:
NebuSelect™ Recombinant Human Fas Ligand/TNFSF6, His-tag(Cat#NBL-242688) is expressed in HEK293 with His tag at the N-Terminus.It contains Pro134-Leu281.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 18 kDa. Due to glycosylation, the protein migrates to 20-35 kDa based on Bis-Tris PAGE result.
Target Name:
Fas Ligand/TNFSF6; APTL; CD95-L; Fas ligand; APT1LG1; TNFSF6; FASLG; ALPS1B; CD178; FASL; TNLG1A
Target Information:
Fas ligand (FasL, CD95L) is a 40-kDa type II transmembrane protein that binds to Fas (CD95) receptors and promotes programmed cell death. Fas receptors are expressed at higher levels in many tumors than in normal cells.Somewhat paradoxically, elimination of Fas or FasL from tumors also leads to death induced by CD95 receptor/ligand elimination (DICE).
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.